1 Min Read
Jan 12 (Reuters) - Integral Diagnostics Ltd:
* EXPECTS ACHIEVEMENT OF FULL YEAR NORMALISED NPAT GROWTH OF AROUND 20% (BEFORE TAKEOVER RESPONSE COSTS AND TRANSACTION COSTS) Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.